Apogee Therapeutics (APGE) Insider Trading & Ownership $51.35 +4.11 (+8.71%) As of 11:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apogee Therapeutics (NASDAQ:APGE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.77%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$990.80KNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$5.74M Get APGE Insider Trade Alerts Want to know when executives and insiders are buying or selling Apogee Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APGE Insider Buying and Selling by Quarter Apogee Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/1/2025Carl DambkowskiInsiderSell5,110$39.80$203,378.00 9/3/2025Carl DambkowskiInsiderSell2,725$37.87$103,195.75 8/6/2025Carl DambkowskiInsiderSell2,725$37.78$102,950.50 7/2/2025Carl DambkowskiInsiderSell10,090$45.09$454,958.10 6/4/2025Carl DambkowskiInsiderSell2,725$36.96$100,716.00 5/7/2025Carl DambkowskiInsiderSell2,725$35.75$97,418.75 4/2/2025Carl DambkowskiInsiderSell3,860$36.22$139,809.20 3/5/2025Carl DambkowskiInsiderSell1,590$30.48$48,463.20 3/5/2025Michael Thomas HendersonCEOSell10,000$30.15$301,500.00 2/5/2025Carl DambkowskiInsiderSell3,520$40.69$143,228.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/5/2025Michael Thomas HendersonCEOSell15,000$40.58$608,700.00 1/8/2025Michael Thomas HendersonCEOSell15,000$48.85$732,750.00 1/2/2025Carl DambkowskiInsiderSell4,085$46.94$191,749.90 12/12/2024Mark C MckennaDirectorBuy20,000$49.54$990,800.00 12/11/2024Carl DambkowskiInsiderSell4,540$48.76$221,370.40 12/4/2024Carl DambkowskiInsiderSell6,665$46.07$307,056.55 12/4/2024Michael Thomas HendersonCEOSell15,000$46.58$698,700.00 11/6/2024Carl DambkowskiInsiderSell6,665$59.12$394,034.80 11/6/2024Michael Thomas HendersonCEOSell15,000$59.22$888,300.00 (Data available from 1/1/2013 forward) APGE Insider Trading Activity - Frequently Asked Questions Who is on Apogee Therapeutics' Insider Roster? The list of insiders at Apogee Therapeutics includes Carl Dambkowski, Jane Henderson, Mark C Mckenna, Michael Thomas Henderson, and Nimish P Shah. Learn more on insiders at APGE. What percentage of Apogee Therapeutics stock is owned by insiders? 42.77% of Apogee Therapeutics stock is owned by insiders. Learn more on APGE's insider holdings. Which Apogee Therapeutics insiders have been buying company stock? The following insider purchased APGE shares in the last 24 months: Mark C Mckenna ($990,800.00). How much insider buying is happening at Apogee Therapeutics? Insiders have purchased a total of 20,000 APGE shares in the last 24 months for a total of $990,800.00 bought. Which Apogee Therapeutics insiders have been selling company stock? The following insiders have sold APGE shares in the last 24 months: Carl Dambkowski ($3,724,016.70), Jane Henderson ($289,560.00), and Michael Thomas Henderson ($9,567,650.00). How much insider selling is happening at Apogee Therapeutics? Insiders have sold a total of 294,685 Apogee Therapeutics shares in the last 24 months for a total of $13,581,226.70 sold. Apogee Therapeutics Key ExecutivesDr. Michael Thomas Henderson M.D. (Age 34)CEO & Director Compensation: $1.17MMs. Jane Pritchett V. Henderson (Age 58)Chief Financial Officer Compensation: $843.64kDr. Carl Linden Dambkowski M.D. (Age 38)Chief Medical Officer Compensation: $870.83kMs. Noel KurdiVice President of Investor RelationsMr. Matthew Batters J.D. (Age 48)Chief Legal Officer & Corporate Secretary Ms. Emily CoxVP & Head of PeopleDr. Rebecca Dabora Ph.D. (Age 64)Chief Development Officer Ms. Wendy Aspden-CurranSenior Vice President of Clinical OperationsDr. Drew Badger Ph.D.Senior VP and Head of Regulatory Affairs & ToxicologyMs. Monica Forbes (Age 48)Senior Vice President of Finance More Insider Trading Tools from MarketBeat Related Companies MRUS Insider Trading RNA Insider Trading GRFS Insider Trading CYTK Insider Trading RYTM Insider Trading CRSP Insider Trading NUVL Insider Trading AXSM Insider Trading TGTX Insider Trading PCVX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:APGE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
